E Fund Management Co., Ltd. Relay Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 17,654 shares of RLAY stock, worth $74,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,654
Previous 11,550
52.85%
Holding current value
$74,499
Previous $81,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
203Shares Held
157MCall Options Held
192KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$118 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$44.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$39 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$31.1 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $507M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...